D.A. Davidson & CO. boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 89.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,959 shares of the company's stock after buying an additional 4,237 shares during the quarter. D.A. Davidson & CO.'s holdings in GE HealthCare Technologies were worth $700,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the stock. Truist Financial Corp increased its holdings in shares of GE HealthCare Technologies by 1.9% during the 4th quarter. Truist Financial Corp now owns 82,770 shares of the company's stock valued at $6,471,000 after acquiring an additional 1,528 shares during the last quarter. CIBC Asset Management Inc grew its holdings in GE HealthCare Technologies by 3.5% during the fourth quarter. CIBC Asset Management Inc now owns 146,218 shares of the company's stock valued at $11,431,000 after purchasing an additional 5,009 shares during the last quarter. State of New Jersey Common Pension Fund D grew its holdings in GE HealthCare Technologies by 3.1% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 161,590 shares of the company's stock valued at $12,633,000 after purchasing an additional 4,854 shares during the last quarter. J.W. Cole Advisors Inc. raised its position in shares of GE HealthCare Technologies by 25.5% in the fourth quarter. J.W. Cole Advisors Inc. now owns 3,785 shares of the company's stock valued at $296,000 after purchasing an additional 768 shares during the period. Finally, Strategic Financial Concepts LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $1,326,000. 82.06% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $97.67.
Get Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Price Performance
GEHC traded down $2.05 during midday trading on Friday, reaching $87.35. 4,214,323 shares of the company's stock were exchanged, compared to its average volume of 2,884,411. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The firm has a market capitalization of $39.94 billion, a price-to-earnings ratio of 20.17, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The business has a 50-day simple moving average of $86.00 and a two-hundred day simple moving average of $86.07. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
